Cargando…
Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible...
Autores principales: | Dong, Baiqiang, Zhu, Xuan, Chen, Runzhe, Wu, Qing, Jin, Jia’nan, Wang, Lin, Xu, Yujin, Chen, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857614/ https://www.ncbi.nlm.nih.gov/pubmed/36673123 http://dx.doi.org/10.3390/diagnostics13020313 |
Ejemplares similares
-
Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study
por: Dong, Baiqiang, et al.
Publicado: (2023) -
Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors
por: Xie, Xuyun, et al.
Publicado: (2020) -
Neutrophil-to-lymphocyte ratio as a prognostic predictor for patients with cancer treated with stereotactic body radiation therapy: A meta-analysis
por: Yu, Yipin, et al.
Publicado: (2022) -
Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
por: Huang, Karen, et al.
Publicado: (2023) -
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
por: Reddy, Abhinav V., et al.
Publicado: (2022)